Table 2.
Baseline Demographics and Clinical Characteristics
| Completers (n = 33) M (SD) | Non-Completers (n = 7) M (SD) | Controls (n = 41) M (SD) | |
|---|---|---|---|
| Age | 29.24 (6.81) | 29.29 (8.62) | 28.20 (7.87) |
| NART | 105.15 (8.61) | 104.29 (10.19) | 111.44 (8.69)** |
| BMI | 27.37 (8.62) | 30.33 (7.83) | 24.25 (4.53)* |
| FT (pmol/L) | 30.52 (14.71) | 31.29 (11.97) | 19.32 (8.27)*** |
| HADS | 12.48 (6.91) | 16.43 (8.22) | 9.73 (6.20)* |
| HADS-A | 7.67 (3.81) | 9.86 (4.74) | 6.73 (3.65) |
| HADS-D | 4.82 (4.00) | 6.57 (4.16) | 3.00 (3.36)* |
Note: *p<0.05, **p<0.01, ***p<0.001, referring to comparison between completers and controls. Normal range for free testosterone in women = 2.0–24pmol/L.
Abbreviations: BMI, body mass index; FT, free testosterone; HADS, Hospital Anxiety and Depression Scale; HADS-A, Hospital Anxiety and Depression Scale – Anxiety subscale; HADS-D, Hospital Anxiety and Depression Scale – Depression subscale; NART, National Adult Reading Test.